153 related articles for article (PubMed ID: 20299499)
1. A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS).
Yoshikawa T; Tsuburaya A; Morita S; Kodera Y; Ito S; Cho H; Miyashita Y; Sakamoto J
Jpn J Clin Oncol; 2010 Apr; 40(4):369-72. PubMed ID: 20299499
[TBL] [Abstract][Full Text] [Related]
2. A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomized phase II trial (COMPASS-D trial).
Yoshikawa T; Taguri M; Sakuramoto S; Kunisaki C; Fukunaga T; Ito S; Cho H; Tanabe K; Nishikawa K; Matsui T; Morita S; Tsuburaya A
Jpn J Clin Oncol; 2012 Jan; 42(1):74-7. PubMed ID: 22102736
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
[TBL] [Abstract][Full Text] [Related]
4. Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial.
Yoshikawa T; Tanabe K; Nishikawa K; Ito Y; Matsui T; Kimura Y; Hirabayashi N; Mikata S; Iwahashi M; Fukushima R; Takiguchi N; Miyashiro I; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J
Ann Surg Oncol; 2014 Jan; 21(1):213-9. PubMed ID: 23838904
[TBL] [Abstract][Full Text] [Related]
5. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer.
Yoshikawa T; Morita S; Tanabe K; Nishikawa K; Ito Y; Matsui T; Fujitani K; Kimura Y; Fujita J; Aoyama T; Hayashi T; Cho H; Tsuburaya A; Miyashita Y; Sakamoto J
Eur J Cancer; 2016 Jul; 62():103-11. PubMed ID: 27244537
[TBL] [Abstract][Full Text] [Related]
6. [The future of loco-regional treatment for advanced gastric cancer].
Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
[TBL] [Abstract][Full Text] [Related]
7. Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer.
Kim JY; Do YR; Park KU; Kim JG; Chae YS; Kim MK; Lee KH; Ryoo HM; Bae SH; Baek JH; Song HS
Cancer Chemother Pharmacol; 2011 Mar; 67(3):527-32. PubMed ID: 20461377
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
[TBL] [Abstract][Full Text] [Related]
9. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
[TBL] [Abstract][Full Text] [Related]
11. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
12. Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer.
Nashimoto A; Yabusaki H; Nakagawa S; Takii Y; Tsuchiya Y; Otsuo T
Anticancer Res; 2009 Nov; 29(11):4689-96. PubMed ID: 20032421
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Kimura Y; Yano H; Imamura H; Fujitani K; Imano M; Tokunaga Y; Matsuoka M; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Jpn J Clin Oncol; 2013 Feb; 43(2):125-31. PubMed ID: 23225911
[TBL] [Abstract][Full Text] [Related]
14. A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.
Tsuburaya A; Sakamoto J; Morita S; Kodera Y; Kobayashi M; Miyashita Y; Macdonald JS
Jpn J Clin Oncol; 2005 Nov; 35(11):672-5. PubMed ID: 16275676
[TBL] [Abstract][Full Text] [Related]
15. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
[TBL] [Abstract][Full Text] [Related]
16. A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Horiuchi Y; Kumada S; Haruta J; Yamaguchi T; Sugihara M; Ina K; Kusugami K; Goto S
Anticancer Res; 2005; 25(2B):1297-301. PubMed ID: 15865081
[TBL] [Abstract][Full Text] [Related]
17. A phase I study of S-1 administration and a 24-h infusion of cisplatin plus paclitaxel in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Okeya M; Kobayashi K; Hibino Y; Watanabe H; Goto H
Anticancer Res; 2006; 26(2B):1605-9. PubMed ID: 16619579
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
19. [Complete resection of advanced gastric cancer with multiple liver metastases following a bypass operation and one year of chemotherapy].
Yajima K; Kobayashi T; Ohashi M; Kurosaki R; Kurosaki I; Matsuo H; Hatakeyama K
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1283-6. PubMed ID: 17687214
[TBL] [Abstract][Full Text] [Related]
20. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T;
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
